 Founded in 1964
| The Dermatology Foundation Established in 1964, the Foundation is a 501(c)3 charitable organization dedicated to enabling advancements in patient care. The DF accomplishes this important work by providing research funding each year to promising early and mid-career investigators whose novel ideas have the potential to shape the future of the specialty. Thanks to its many physician members and industry constituents over more than five decades, the DF funding has had a tremendous long-term effect on the specialty. Foundation support has helped to:
With the continued support of dermatologists, specialty societies and corporate supporters, the DF can continue to further progress in all areas of the specialty, for the benefit of patients everywhere.  A Special Message from the DF President: First and foremost, I hope you are safe and well during a very difficult personal and professional time. If you are a DF member, or an industry or society supporter, I also wanted to share my sincere thanks for your continued commitment to the Foundation. With your help, we were able to fulfill our mission this year—to fund promising research that will enable advancements in patient care. The DF and our newest award recipients are fortunate to have your support. We are all operating in new territory, and we do not know what the future will bring. However, there will always be patients who will need the help only our specialty can provide. If we all work together, we will be able to expand the tools and treatments available to dermatologists everywhere. My best wishes for your health and safety. Sincerely, Janet Janet A. Fairley, MD The DF: Where Innovation Begins
The long-term results of the Dermatology Foundation's work are profound. For over 50 years, the DF has focused on furthering patient care by funding innovative research pursued by promising investigators. It has identified and launched a pool of innovators who have brought the specialty a greater understanding of dermatologic diseases—and new treatments—benefiting patients everywhere. A shining example of this has been the wonderful contributions DF-funded investigators have made to the current treatment of psoriasis. |
|
